BioWorld Asia

July 7, 2010

View Archived Issues

Study Reveals a Dozen New Diabetes Genes to Explore

Read More

Galapagos Enters $374M Osteoarthritis Pact with Servier

Read More

Swedish Orphan Biovitrum Eyes Manchurian Drug Candidates

Read More

Corrections & Clarifications

Read More

Postive Results Reported for NovaBiotics' Fungal Therapy

Read More

Other News To Note

Read More

Intercell's Adjuvant Patch Fails to Boost Pandemic Flu Vaccine

A faulty hemagglutinin inhibition assay may be the reason underlying the failure of a Phase II clinical trial of Intercell AG's investigational Vaccine Enhancement Patch (VEP) for H5N1 influenza. (BioWorld International) Read More

Germany Funds Biobank Targeting Chronic Diseases

Read More